Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: Antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulinBehavioral: Diabetes survival skills self-management education
- Registration Number
- NCT01033773
- Lead Sponsor
- Medstar Health Research Institute
- Brief Summary
To demonstrate that a focused Emergency Department (ED) intervention for uncontrolled hyperglycemia enables safe and effective glycemic management and reduces emergency room re-visits. We assessed hypoglycemia BG \< 60mg/dL; change in mean blood glucose and A1C, and ED revisits for hyperglycemia.
- Detailed Description
Patients with BG \> 200mg/dL presenting to an urban tertiary care hospital ED were enrolled in a 4 week prospective intervention with historic self-controls. Subjects returned at 12-72 hours, 2 and 4 weeks. Diabetes medications (including sulfonylureas, metformin and/or insulin) were initiated and/or adjusted at each visit using the intervention algorithm per presenting blood glucose and prior diabetes medications. Survival skills self-management education and navigation to outpatient services were provided.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 86
- Age > 18 years
- Type 2 Diabetes Mellitus,
- random BG > 200 mg/dL,
- willing and able to provide informed consent and to participate in diabetes self-management education (DSME)
- stable for discharge from the ED once hyperglycemia treatment initiated.
- type 1 Diabetes Mellitus,
- diabetic ketoacidosis or hyperosmolar non-ketotic state,
- concomitant treatment with glucocorticoids (other than stable maintenance dose therapy),
- cognitive or physical impairment preventing participation in DSME
- unwillingness or inability to provide consent and/or attend follow-up visits.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Diabetes education and medication management Diabetes survival skills self-management education All enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post. Diabetes education and medication management Antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin All enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post.
- Primary Outcome Measures
Name Time Method Total Number of Hypoglycemia Events (Blood Glucose < 60mg/dL) Within 24 Hours of Baseline Visit 24 hours Total Number of hypoglycemic events defined as Blood Glucose \< 60 within 24 hours of index emergency room visit (baseline)
- Secondary Outcome Measures
Name Time Method Change in Hemoglobin A1C From Baseline to End of Intervention at 30 Days 30 days difference between mean hemoglobin A1C at baseline and mean Hemoglobin A1C to end of intervention
Change in Mean Blood Glucose From Time of Presentation to Emergency Room to End of Intervention 30 Days From Baseline 30 days Mean difference in of blood glucose in mg/dl between baseline mean BG and end of intervention mean BG 30 days from baseline
Trial Locations
- Locations (1)
Washington Hospital Center
🇺🇸Washington, District of Columbia, United States